repurposing semaglutide and liraglutide for alcohol use disorder GLP-1 receptor agonists disorder: a systematic review meta-analysis | Diabetology & Metabolic Syndrome The weight-loss drug Wegovy may

As with other agents that cause significant weight loss or gastrointestinal fluid losses, there are theoretical class-related risks that warrant attention, including gallbladder disease (cholelithiasis and cholecystitis have been reported with GLP-1 receptor agonists), and dehydration or acute kidney injury in the context of persistent vomiting or diarrhoea

The results from these studies are largely positive

There is 1 item in your cart

[11] As a precautionary measure, individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are typically excluded from trials